Tekeli Oya, Köse Helin Ceren
Department of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey.
Ocul Immunol Inflamm. 2023 Apr;31(3):541-549. doi: 10.1080/09273948.2022.2042315. Epub 2022 May 6.
The purpose of this study was to analyse the changes in flare values after Micropulse Transscleral Laser Treatment for Glaucoma (MP-TLT) in patients with refractory glaucoma and to compare with the outcomes of patients who underwent continuous wave (CW) diode laser cyclophotocoagulation (CW-TSCPC).
In this single-centre study, we reviewed the medical records of 54 patients who underwent MP-TLT and 35 patients who underwent CW-TSCPC at Ankara University Faculty of Medicine, Department of Ophthalmology. Aqueous flare values were measured by laser flare photometry.
The mean laser flare values in both groups (MP-TLT/CW-TSCPC) increased after surgery from 20.85 ± 8.74/22.14 ± 7.39 ph/ms at baseline to 48.52 ± 18.23/57.38 ± 20.08 ph/ms (P = .001) on day 1 and then progressively decreased to 44.13 ± 18.32/52.24 ± 20.56 in week 1, 40.5 ± 18.5/48.24 ± 19.23 week 2 and 35.28 ± 17.09/41.11 ± 16.7 month 1 (all p < .05) and returned to similar levels to baseline at month 3 and month 6 (both p > .05). Patients who achieved treatment success had significantly higher flare values than patients who failed on post-operative day 1, week 1 and week 2 in both groups. The flare values were significantly lower in the MP-TLT group than the CW-TSCPC group on post-operative day 1, week 1, week 2 and month 1 (all p < .05). There were no cases of prolonged post-operative inflammation or serious complications in both groups.
Intraocular inflammation, quantified by aqueous flare, may be a contributing factor to the IOP lowering effect of transscleral diode laser cyclophotocoagulation in the early post-operative period.
本研究旨在分析难治性青光眼患者接受微脉冲经巩膜激光治疗青光眼(MP-TLT)后闪光值的变化,并与接受连续波(CW)二极管激光睫状体光凝术(CW-TSCPC)的患者的结果进行比较。
在这项单中心研究中,我们回顾了安卡拉大学医学院眼科接受MP-TLT的54例患者和接受CW-TSCPC的35例患者的病历。通过激光闪光光度法测量房水闪光值。
两组(MP-TLT/CW-TSCPC)术后平均激光闪光值从基线时的20.85±8.74/22.14±7.39ph/ms在术后第1天增加到48.52±18.23/57.38±20.08ph/ms(P = .001),然后在第1周逐渐降至44.13±18. .32/52.24±20.56,第2周降至40.5±18.5/48.24±19.23,第1个月降至35.28±17.09/41.11±16.7(所有p < .05),并在第3个月和第6个月恢复到与基线相似的水平(两者p > .05)。在两组中,治疗成功的患者在术后第1天、第1周和第2周的闪光值显著高于治疗失败的患者。在术后第1天、第1周、第2周和第1个月,MP-TLT组的闪光值显著低于CW-TSCPC组(所有p < .05)。两组均无术后炎症延长或严重并发症的病例。
通过房水闪光量化的眼内炎症可能是术后早期经巩膜二极管激光睫状体光凝术降低眼压效果的一个促成因素。